ANTERIS TECHNOLOGIES GLOBAL (AVR) Stock Price, Quote, News and Overview
NASDAQ:AVR - Nasdaq - US03675P1021 - Common Stock - Currency: USD
AVR Quote, Performance and Key Statistics
7.56
-0.33 (-4.18%)
The current stock price of AVR is 7.56 USD. In the past month the price increased by 22.13%.
AVR Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 29.37 | 237.84B | ||
| ISRG | INTUITIVE SURGICAL INC | 70.7 | 184.84B | ||
| BSX | BOSTON SCIENTIFIC CORP | 39.49 | 146.29B | ||
| SYK | STRYKER CORP | 31.12 | 144.73B | ||
| MDT | MEDTRONIC PLC | 17.7 | 121.20B | ||
| BDX | BECTON DICKINSON AND CO | 16.5 | 65.91B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.84 | 41.35B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 19.28 | 39.59B | ||
| IDXX | IDEXX LABORATORIES INC | 38.23 | 34.98B | ||
| RMD | RESMED INC | 26.29 | 34.14B | ||
| DXCM | DEXCOM INC | 47.18 | 30.42B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 18.25 | 25.91B |
Related stock screener links
About AVR
Company Profile
Anteris Technologies Global Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Eagan, Minnesota and currently employs 138 full-time employees. The company went IPO on 2024-12-13. Anteris Technologies Global Corp. is a structural heart company engaged in discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. The company is engaged in the research and development of its biomimetic technology (ADAPT, DurAVR Transcatheter Heart Valve (THV), ComASUR Transfemoral Delivery System) to address unmet medical needs in the treatment of aortic stenosis. The DurAVR THV, with its single piece, native-shaped biomimetic design is built to mimic the performance of a healthy aortic valve and to restore normal laminar (smooth) blood flow. This class of technology can be used to treat new aortic stenosis patients and to treat aortic stenosis patients with failed valves (valve-in-valve). ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. ComASUR is its balloon-expandable delivery system.
Company Info
ANTERIS TECHNOLOGIES GLOBAL
860 Blue Gentian Road, Suite 340
Eagan MINNESOTA US
Employees: 138
Phone: 16514930606
ANTERIS TECHNOLOGIES GLOBAL / AVR FAQ
What is the stock price of ANTERIS TECHNOLOGIES GLOBAL today?
The current stock price of AVR is 7.56 USD. The price decreased by -4.18% in the last trading session.
What is the ticker symbol for ANTERIS TECHNOLOGIES GLOBAL stock?
The exchange symbol of ANTERIS TECHNOLOGIES GLOBAL is AVR and it is listed on the Nasdaq exchange.
On which exchange is AVR stock listed?
AVR stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ANTERIS TECHNOLOGIES GLOBAL stock?
8 analysts have analysed AVR and the average price target is 16.83 USD. This implies a price increase of 122.62% is expected in the next year compared to the current price of 7.56. Check the ANTERIS TECHNOLOGIES GLOBAL stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ANTERIS TECHNOLOGIES GLOBAL worth?
ANTERIS TECHNOLOGIES GLOBAL (AVR) has a market capitalization of 272.31M USD. This makes AVR a Micro Cap stock.
How many employees does ANTERIS TECHNOLOGIES GLOBAL have?
ANTERIS TECHNOLOGIES GLOBAL (AVR) currently has 138 employees.
What are the support and resistance levels for ANTERIS TECHNOLOGIES GLOBAL (AVR) stock?
ANTERIS TECHNOLOGIES GLOBAL (AVR) has a support level at 7.25. Check the full technical report for a detailed analysis of AVR support and resistance levels.
Is ANTERIS TECHNOLOGIES GLOBAL (AVR) expected to grow?
The Revenue of ANTERIS TECHNOLOGIES GLOBAL (AVR) is expected to grow by 8.02% in the next year. Check the estimates tab for more information on the AVR EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ANTERIS TECHNOLOGIES GLOBAL (AVR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AVR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AVR, evaluating the profitability, health, valuation and growth aspects
- ANTERIS TECHNOLOGIES GLOBAL (AVR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ANTERIS TECHNOLOGIES GLOBAL (AVR) Sales and EPS estimates to see what analysts future expectations are.
- ANTERIS TECHNOLOGIES GLOBAL (AVR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ANTERIS TECHNOLOGIES GLOBAL (AVR) Insider and Institutional Ownership to learn about the owners and their transactions.
- ANTERIS TECHNOLOGIES GLOBAL (AVR) Stock Chart to make your own analysis
- ANTERIS TECHNOLOGIES GLOBAL (AVR) Latest news and press-releases to stay up to date.
Does ANTERIS TECHNOLOGIES GLOBAL (AVR) stock pay dividends?
AVR does not pay a dividend.
What is the Price/Earnings (PE) ratio of ANTERIS TECHNOLOGIES GLOBAL (AVR)?
ANTERIS TECHNOLOGIES GLOBAL (AVR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.28).
What is the Short Interest ratio of ANTERIS TECHNOLOGIES GLOBAL (AVR) stock?
The outstanding short interest for ANTERIS TECHNOLOGIES GLOBAL (AVR) is 0.19% of its float. Check the ownership tab for more information on the AVR short interest.
AVR Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to AVR.
AVR Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to AVR. Both the profitability and financial health of AVR have multiple concerns.
AVR Financial Highlights
Over the last trailing twelve months AVR reported a non-GAAP Earnings per Share(EPS) of -1.28. The EPS decreased by -50.58% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -218.09% | ||
| ROE | -1461.24% | ||
| Debt/Equity | 0.02 |
AVR Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to AVR. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of -130.32% and a revenue growth 8.02% for AVR